Live today at 11 AM ET: Viral Vector for Rare and Ultra-Rare Disease
Preview text: Artis BioSolutions 96 There is still time to register, and every registrant gets the…

Use this example
- Subject
- Live today at 11 AM ET: Viral Vector for Rare and Ultra-Rare Disease
- Preview text
- Artis BioSolutions 96 There is still time to register, and every registrant gets the…
- From
- contact@
artisbiosolutions.com - Brand
- Landmark Bio
- ESP
- HubSpot
- Sent
- Tue Oct 20, 2026, 7:04 AM ET
- Size
- 84 KB
- Images
- 7
- Links
- 29, 2 of them buttons
- Subject length
- 69 characters
Against Landmark Bio's usual
Sent in the 7 AM hour, which holds 11% of its emails; 22% arrive in the 1 PM hour. The subject is 69 characters; its average is 54.
Email headers
What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.
- From
- Artis BioSolutions <[email protected]>
- Reply-To
- [email protected]
- Subject
- Live today at 11 AM ET: Viral Vector for Rare and Ultra-Rare Disease
- Date
- Tue, 20 Oct 2026 07:04:32 -0400
- Message-ID domain
- bf07x.hubspotemail.net
- Return-Path domain
- bf07x.hubspotemail.net
- DKIM signature
- d=bf07x.hubspotemail.net s=hs2; d=artisbiosolutions.com s=hs1-24201360
- List-Unsubscribe
- Present, one-click
- Feedback-ID sender
- HubSpot
Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To
Sent just before and after
| Nov 11, 2026 4:25 PM | A 50 L AAV9 process, documented end to end | |
| Oct 21, 2026 1:05 PM | We're Less Prepared Than We Were in 2019 | |
| Oct 20, 2026 7:04 AM | Live today at 11 AM ET: Viral Vector for Rare and Ultra-Rare Disease (this email) | |
| Oct 19, 2026 11:25 AM | Webinar Oct 20: Viral Vector Manufacturing for Rare and Ultra-Rare Disease | |
| Oct 2, 2026 5:46 PM | Kate E. Broderick, Ph.D. on What Synthetic DNA Removes | |
| Sep 29, 2026 5:37 PM | Where to find us in October | |
| Sep 24, 2026 6:07 PM | Redefining AAV manufacturing: a 30-minute Live30 on Sept 30 |
More from Landmark Bio
All Landmark Bio emailsA 50 L AAV9 process, documented end to end
Nov 11, 2026 4:25 PM
We're Less Prepared Than We Were in 2019
Oct 21, 2026 1:05 PM
Webinar Oct 20: Viral Vector Manufacturing for Rare and Ultra-Rare Disease
Oct 19, 2026 11:25 AM
Kate E. Broderick, Ph.D. on What Synthetic DNA Removes
Oct 2, 2026 5:46 PM
Sep 29, 2026 5:37 PM
Redefining AAV manufacturing: a 30-minute Live30 on Sept 30
Sep 24, 2026 6:07 PM





